Comparing Short-term and Oncologic Outcomes of Minimally Invasive Versus Open Pancreaticoduodenectomy Across Low and High Volume Centers
- PMID: 29771723
- DOI: 10.1097/SLA.0000000000002810
Comparing Short-term and Oncologic Outcomes of Minimally Invasive Versus Open Pancreaticoduodenectomy Across Low and High Volume Centers
Abstract
Objective: To compare short-term and oncologic outcomes of patients with cancer who underwent open pancreaticoduodenectomy (OPD) versus minimally invasive pancreaticoduodenectomy (MIPD) using the National Cancer Database.
Summary background data: MIPD, including laparoscopic and robotic approaches, has continued to gain acceptance despite prior reports of increased short-term mortality when compared with OPD.
Methods: Patients with pancreatic cancer diagnosed from 2010 to 2015 undergoing curative intent resection were selected from the National Cancer Database. Patients submitted to OPD were compared with those submitted to MIPD. Laparoscopic and robotic approaches were included in the MIPD cohort. The primary outcome was 90-day mortality; secondary outcomes included 30-day mortality, hospital length of stay, unplanned 30-day readmission, surgical margins, number of lymph nodes harvested, and receipt of adjuvant chemotherapy. Propensity score-weighted random effects logistic regression models were used to examine the adjusted association between surgical approach and the specified outcomes.
Results: Between 2010 and 2015, 22,013 patients underwent OPD or MIPD for pancreatic cancer and 3754 (17.1%) were performed minimally invasively. On multivariable analysis, there was no difference in 90-day mortality between MIPD and OPD (OR, 0.92; 95% CI, 0.75-1.14). Patients undergoing MIPD were less likely to stay in the hospital for a prolonged time (OR, 0.75; 95% CI, 0.68-0.82). 30-day mortality, unplanned readmissions, margins, lymph nodes harvested, and receipt of adjuvant chemotherapy were equivalent between groups. Regardless of surgical approach, patients operated on at high volume centers had reduced 90-day mortality.
Conclusion: Patients selected to receive MIPD for cancer have equivalent short-term and oncologic outcomes, when compared with patients who undergo OPD.
Similar articles
-
Minimally Invasive Versus Open Pancreaticoduodenectomy for Cancer: Practice Patterns and Short-term Outcomes Among 7061 Patients.Ann Surg. 2015 Aug;262(2):372-7. doi: 10.1097/SLA.0000000000001055. Ann Surg. 2015. PMID: 26158612
-
Comparing oncologic and surgical outcomes of robotic and laparoscopic pancreatoduodenectomy in patients with pancreatic cancer: a propensity-matched analysis.Surg Endosc. 2024 May;38(5):2602-2610. doi: 10.1007/s00464-024-10783-1. Epub 2024 Mar 18. Surg Endosc. 2024. PMID: 38498210 Free PMC article.
-
Robotic-assisted versus laparoscopic pancreaticoduodenectomy: oncological outcomes.Surg Endosc. 2018 Jun;32(6):2907-2913. doi: 10.1007/s00464-017-6002-2. Epub 2017 Dec 26. Surg Endosc. 2018. PMID: 29280014
-
Minimally invasive versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma: Individual patient data meta-analysis of randomized trials.Eur J Surg Oncol. 2023 Aug;49(8):1351-1361. doi: 10.1016/j.ejso.2023.03.227. Epub 2023 Apr 7. Eur J Surg Oncol. 2023. PMID: 37076411
-
Is total laparoscopic pancreaticoduodenectomy superior to open procedure? A meta-analysis.World J Gastroenterol. 2019 Oct 7;25(37):5711-5731. doi: 10.3748/wjg.v25.i37.5711. World J Gastroenterol. 2019. PMID: 31602170 Free PMC article.
Cited by
-
Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.Int J Mol Sci. 2021 Mar 6;22(5):2655. doi: 10.3390/ijms22052655. Int J Mol Sci. 2021. PMID: 33800786 Free PMC article.
-
The Practice of Pancreatoduodenectomy in India: A Nation-Wide Survey.Cureus. 2023 Jul 13;15(7):e41828. doi: 10.7759/cureus.41828. eCollection 2023 Jul. Cureus. 2023. PMID: 37575744 Free PMC article.
-
ASO Author Reflections: An Objective Hospital Volume Threshold for Minimally Invasive Pancreaticoduodenectomy.Ann Surg Oncol. 2022 Mar;29(3):1575-1576. doi: 10.1245/s10434-021-11022-w. Epub 2021 Nov 12. Ann Surg Oncol. 2022. PMID: 34773192 Free PMC article. No abstract available.
-
Mortality factors in pancreatic surgery: A systematic review. How important is the hospital volume?Int J Surg. 2022 May;101:106640. doi: 10.1016/j.ijsu.2022.106640. Epub 2022 May 4. Int J Surg. 2022. PMID: 35525416 Free PMC article.
-
Defining Facility Volume Threshold for Optimization of Short- and Long-Term Outcomes in Patients Undergoing Resection of Perihilar Cholangiocarcinoma.J Gastrointest Surg. 2023 Apr;27(4):730-740. doi: 10.1007/s11605-022-05465-z. Epub 2022 Sep 22. J Gastrointest Surg. 2023. PMID: 36138311
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical